Bempedoic Acid Pregnancy Surveillance Program
Part of paid clinical trials in Morrisville, North Carolina.
- Sponsor
- Esperion Therapeutics, Inc.
- Study ID
- NCT05103254
- Status
- Recruiting
Conditions
- Hyperlipidemias
- Pregnancy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bempedoic Acid — DRUGBempedoic Acid 180 MG
- Bempedoic Acid / Ezetimibe — DRUGBempedoic Acid 180 MG / Ezetimibe 10 MG
Study Details
Bempedoic acid pregnancy surveillance program
Key Dates
- Start date
- Sep 1, 2021
- Status verified
- May 2024
- Primary completion
- May 31, 2032
- Completion
- May 31, 2032
Study Design
- Enrollment
- 20 participants (estimated)
Primary Outcome Measure
Major congenital malformations (MCM) [ Time Frame: Birth up to 12 months ]
Central Contacts
- Esperion Therapuetics1 833 377 7633 (Option 5)
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Evidera, PPD business unit | Morrisville | North Carolina | 27560 | - |
Find similar trials in Morrisville, NC
By research site
Related Studies
- Prenatal Exposure Effects Psychophysiology StudyEnrolling By Invitation · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina
- Pregnancy Exercise Mode Effect on Childhood ObesityRecruiting · East Carolina University · Greenville, North Carolina
- CGM for Management of Type 2 Diabetes in PregnancyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) DisparitiesNot Yet Recruiting · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina